BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 386963)

  • 21. Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study.
    Watkins WM; Brandling-Bennett AD; Nevill CG; Carter JY; Boriga DA; Howells RE; Koech DK
    Trans R Soc Trop Med Hyg; 1988; 82(3):398-403. PubMed ID: 3068855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
    Peters W; Stewart LB; Robinson BL
    Ann Trop Med Parasitol; 2005 Jul; 99(5):457-72. PubMed ID: 16004705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology of drug-resistant malaria.
    Björkman A; Phillips-Howard PA
    Trans R Soc Trop Med Hyg; 1990; 84(2):177-80. PubMed ID: 2202097
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of herbal antimalarial MAMA decoction-amodiaquine combination in murine malaria model.
    Adepiti AO; Elujoba AA; Bolaji OO
    Pharm Biol; 2016 Oct; 54(10):2298-303. PubMed ID: 27057621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunoelectron-microscopic localization of a 54-kDa protein overexpressed by chloroquine-resistant Plasmodium berghei ANKA strain].
    Li GD; Qu FY; Liu SQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993; 11(2):105-7. PubMed ID: 8174210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of the efficacy of chloroquine and a combination of dapsone and pyrimethamine in the prophylaxis of malaria in Peninsular Malaysia.
    Ponnampalam JT; Seow CL; Roy OS
    J Trop Med Hyg; 1976 Oct; 79(10):220-5. PubMed ID: 796479
    [No Abstract]   [Full Text] [Related]  

  • 27. Exploring the antimalarial potential of whole Cymbopogon citratus plant therapy.
    Chukwuocha UM; Fernández-Rivera O; Legorreta-Herrera M
    J Ethnopharmacol; 2016 Dec; 193():517-523. PubMed ID: 27693771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 54-kDa protein overexpressed by chloroquine-resistant Plasmodium berghei ANKA strain.
    Li GD; Qu FY; Chen X; Ni CR
    Zhongguo Yao Li Xue Bao; 1993 Jan; 14(1):9-12. PubMed ID: 8503289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chemotherapy of rodent malaria, XXVI. The potential value of WR 122,455 (a 9-phenanthrenemethanol) against drug-resistant malaria parasites.
    Peters W; Porter M
    Ann Trop Med Parasitol; 1976 Sep; 70(3):271-81. PubMed ID: 788658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance.
    Peters W
    Exp Parasitol; 1965 Aug; 17(1):80-9. PubMed ID: 5843289
    [No Abstract]   [Full Text] [Related]  

  • 31. Suppression of the chloroquine resistance of Plasmodium berghei by treatment of infected mice with a microsomal monooxygenase inhibitor.
    Rabinovich SA; Kulikovskaya IM; Maksakovskaya EV; Chekhonadskikh TV; Pankova TG; Salganik RI
    Bull World Health Organ; 1987; 65(3):387-9. PubMed ID: 3117394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo and in vitro antimalarial effect and toxicological evaluation of the chloroquine analogue PQUI08001/06.
    Reis PA; Pais KC; Pereira MF; Douradinha B; Costa NF; Kaiser CR; Bozza PT; Areas ALL; Zalis MG; de Lima Ferreira M; de Souza MVN; da Silva Frutuoso V; de Castro-Faria-Neto HC
    Parasitol Res; 2018 Nov; 117(11):3585-3590. PubMed ID: 30145706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative characterization of hemozoin in Plasmodium berghei and vivax.
    Pisciotta JM; Scholl PF; Shuman JL; Shualev V; Sullivan DJ
    Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):110-119. PubMed ID: 28279945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection.
    Visser R; de Mast Q; Munnix I; van der Ven A; Dofferhoff T
    Travel Med Infect Dis; 2016; 14(6):644-645. PubMed ID: 27546283
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversal of chloroquine resistance in murine malaria parasites by prostaglandin derivatives.
    Chandra S; Ohnishi ST; Dhawan BN
    Am J Trop Med Hyg; 1993 May; 48(5):645-51. PubMed ID: 8517483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Severe Plasmodium falciparum malaria attacks during chemoprophylaxis with chloroquine and proguanil].
    Hovette P; Blasco G; Touze JE; Laroche R
    Presse Med; 1992 Jan 4-11; 21(1):41-2. PubMed ID: 1531267
    [No Abstract]   [Full Text] [Related]  

  • 37. [Suppression of chloroquine resistance in Plasmodium berghei by using a microsomal monooxygenase inhibitor].
    Rabinovich SA; Kulikovskaia IM; Maksakovskaia EV; Chekhonadskikh TV; Pankova TG
    Med Parazitol (Mosk); 1986; (4):7-10. PubMed ID: 3093829
    [No Abstract]   [Full Text] [Related]  

  • 38. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
    Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
    Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of malaria chemoprophylaxis with a proguanil-chloroquine combination in Papua New Guinea.
    Henderson A; Simon JW; Melia W
    Trans R Soc Trop Med Hyg; 1986; 80(5):838-40. PubMed ID: 3299896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Resistance of Plasmodium falciparum to the chloroquine-proguanil combination. A case from Benin].
    Martin J; Morand C; M'Baye PS; Oger E; Abgrall J
    Presse Med; 1992 Apr; 21(14):678. PubMed ID: 1534624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.